Cargando…
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells
Melanoma is among the most aggressive cancers due to its tendency to metastasize early. Phenotype switching between a proliferative and an invasive state has been suggested as a critical process for metastasis, though the mechanisms that regulate state transitions are complex and remain poorly under...
Autores principales: | Janssen, Sanne Marlijn, Moscona, Roy, Elchebly, Mounib, Papadakis, Andreas Ioannis, Redpath, Margaret, Wang, Hangjun, Rubin, Eitan, van Kempen, Léon Cornelis, Spatz, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026120/ https://www.ncbi.nlm.nih.gov/pubmed/32123577 http://dx.doi.org/10.1038/s41420-019-0235-x |
Ejemplares similares
-
The Evolution of Epigenetic Regulators CTCF and BORIS/CTCFL in Amniotes
por: Hore, Timothy A., et al.
Publicado: (2008) -
Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells
por: Jones, Tania A., et al.
Publicado: (2011) -
Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2011) -
BORIS/CTCFL is an RNA-binding protein that associates with polysomes
por: Ogunkolade, Babatunji W, et al.
Publicado: (2013) -
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
por: Salgado-Albarrán, Marisol, et al.
Publicado: (2019)